1-3 of 3
Mark M. Stevens
Close
Sort by
Journal Articles

Transcriptomic Correlates of Response to Selinexor in Multiple Myeloma Reveal a Predictive Signature

Paula Restrepo, Sherry Bhalla, Adolfo Aleman, Violetta Leshchenko, Sarita Agte, Yogita Ghodke-Puranik, Joy Jiang, Mark M. Stevens, Deepu Madduri, Joshua Richter, Shambavi Richard, Ajai Chari, Hearn Jay Cho, Sundar Jagannath, Christopher J Walker, Yosef Landesman, Alessandro Lagana, Samir Parekh
Journal: Blood
Blood (2021) 138 (Supplement 1): 457.
https://doi.org/10.1182/blood-2021-150522
Published: 2021
Journal Articles

Triple MAPK Inhibition Salvaged a Relapsed Post BCMA CAR-T Cell Therapy in Multiple Myeloma Patient with BRAF V600E Dominant Clone

Muhammad Elnaggar, David T. Melnekoff, Sarita Agte, Christos Adamopoulos, Mark M. Stevens, Violetta Leshchenko, Katerina Kappes, Daniel Verina, Poulikos I. Poulikakos, Sundar Jagannath, Samir Parekh
Journal: Blood
Blood (2021) 138 (Supplement 1): 4720.
https://doi.org/10.1182/blood-2021-151512
Published: 2021
Journal Articles

Linking Biophysical and Transcriptional Profiles of In Vivo -Treated Human Leukemias on a Single-Cell Level Uniquely Resolves Subpopulations of Response

Mark A. Murakami, MDMA,MMSc, Mark M Stevens, PhD, Robert J Kimmerling, PhD, Alejandro J Gupta, BS, Huiyun Liu, Sanjay M. Prakadan, AB, Alex K. Shalek, PhD, Scott R. Manalis, PhD, David M. Weinstock, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3987.
https://doi.org/10.1182/blood.V130.Suppl_1.3987.3987
Published: 2017